Reminder: Invitation to Roche’s Full Year Results 2021 Presentation Roche will publish its Full Year Results for 2021 prior to the opening of the Swiss Stock Exchange on Thursday, 3 February 2022. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before) Release will be e-mailed and posted on the Roche IR website > click here Presentation slides will be posted on the Roche IR website > click here 14:00 – 16:00 CET / 13:00 – 15:00 GMT 08:00 – 10:00 AM EST / 05:00 - 07:00 AM PST The webinar will start with presentations by senior management, followed by a Q&A session. Presenters: Severin Schwan, CEO Roche Group Bill Anderson, CEO Roche Pharmaceuticals Thomas Schinecker, CEO Roche Diagnostics Alan Hippe, Chief Financial and IT Officer We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com *privacy notice Best regards, Karl Mahler                                                Bruno Eschli Head of Investor Relations                        Head of Investor Relations

  

Roche Investor Relations
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

 

get the latest news and updates to your inbox.